Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. 2013

Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
Medical Research Council Clinical Sciences Centre and National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom.

OBJECTIVE The aim of this study was to ascertain whether coronary microvascular dysfunction (CMD) and inflammation are related in cardiac syndrome X (CSX). BACKGROUND CMD can lead to CSX, defined as typical angina and transient myocardial ischemia despite normal coronary arteriograms. Inflammation has been suggested to play a role in the pathogenesis of myocardial ischemia in CSX. METHODS We assessed 21 CSX patients (age 52 ± 10 years; 17 women) without traditional cardiovascular risk factors and 21 matched apparently healthy control subjects. Positron emission tomography was used to measure myocardial blood flow (MBF) and coronary flow reserve (CFR) in response to intravenous adenosine, whereas high-sensitivity C-reactive protein (CRP) was measured to assess inflammation. Patients were subdivided a priori into 2 groups according to CRP concentrations at study entry (i.e., ≤3 or >3 mg/l). RESULTS There were no differences in resting (1.20 ± 0.23 ml/min/g vs. 1.14 ± 0.20 ml/min/g; p = 0.32) or hyperemic MBF (3.28 ± 1.02 ml/min/g vs. 3.68 ± 0.89 ml/min/g; p = 0.18) between CSX patients and the control group, whereas CFR was mildly reduced in CSX patients compared with the control group (2.77 ± 0.80 vs. 3.38 ± 0.80; p = 0.02). Patients with CRP >3 mg/l had more severe impairment of CFR (2.14 ± 0.33 vs. 3.16 ± 0.76; p = 0.001) and more ischemic electrocardiographic changes during adenosine administration than patients with lower CRP, and a negative correlation between CRP levels and CFR (r = -0.49, p = 0.02) was found in CSX patients. CONCLUSIONS CSX patients with elevated CRP levels had a significantly reduced CFR compared with the control group, which is indicative of CMD. Our study thus suggests a role for inflammation in the modulation of coronary microvascular responses in patients with CSX.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan

Related Publications

Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
August 2009, European heart journal,
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
May 2011, Journal of cardiovascular medicine (Hagerstown, Md.),
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
August 2012, Trends in cardiovascular medicine,
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
June 2013, JACC. Cardiovascular imaging,
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
November 2017, Arquivos brasileiros de cardiologia,
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
September 2016, International journal of cardiology,
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
June 2006, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
February 2023, JACC. Basic to translational science,
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
January 2023, Angiology,
Alejandro Recio-Mayoral, and Ornella E Rimoldi, and Paolo G Camici, and Juan Carlos Kaski
April 2009, Heart (British Cardiac Society),
Copied contents to your clipboard!